- Bladder side effects were experienced half as often with CyberKnife SBRT as with conventional linear accelerator delivered SBRT two years after treatment SUNNYVALE, Calif., Sept. 14, 2021 ...

SUNNYVALE, Calif., Dec. 15, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today it has received approval from the Japanese Ministry of Health, Labor and Welfare (Shonin) to market ...

MADISON, Wis., April 3, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data on the clinical use of the CyberKnife ® System reinforce the device's broad-based ...

SUNNYVALE, Calif., May 22, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Daniela Schmitt, PhD, a medical physicist at Heidelberg University Hospital, took top honors in ...

Accuray Inc. (NASDAQ: ARAY) has a tough row to hoe: Cultivate a market that crosses medical specialty lines for a product that costs millions. The Sunnyvale, Calif.-based company’s CyberKnife system ...

SUNNYVALE, Calif., Dec. 6, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the new release of its Accuray Precision ® Treatment Planning System (TPS) with the CyberKnife ...

SUNNYVALE, Calif., July 12, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new clinical studies presented at the 15 th Congress of the International Stereotactic ...

Accuray Incorporated ARAY recently received approval from the Japanese Ministry of Health, Labor and Welfare (Shonin) with respect to marketing the CyberKnife Robotic Radiosurgery System in Japan.

(MENAFN- PR Newswire) SRS and SBRT are non-surgical procedures that deliver precisely targeted doses of radiotherapy, typically in one to five treatment sessions, with the goal of ablating (destroying ...